These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3315519)

  • 1. Insulin autoantibodies: their role in the pathogenesis of IDDM.
    Palmer JP
    Diabetes Metab Rev; 1987 Oct; 3(4):1005-15. PubMed ID: 3315519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoimmune aspects of insulin-dependent diabetes mellitus. Humoral immunity].
    Efimov AS; Poltorak VV
    Probl Endokrinol (Mosk); 1987; 33(6):80-8. PubMed ID: 3325973
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin, insulin antibodies and insulin autoantibodies.
    Winter WE; Jacobsen LM; Pittman D
    MLO Med Lab Obs; 2017 Feb; 49(2):16-18. PubMed ID: 30005474
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of immunological markers in IDDM after more than 20 years from ICA description.
    Dotta F; Dionisi S; Farilla L; Di Mario U
    Diabetes Metab Rev; 1996 Jul; 12(2):121-6. PubMed ID: 8877281
    [No Abstract]   [Full Text] [Related]  

  • 5. [The molecular genetic aspects of insulin-dependent diabetes mellitus].
    Pankov IuA; Chekhranova MK; Butnev VIu
    Probl Endokrinol (Mosk); 1990; 36(4):3-11. PubMed ID: 2235930
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiopathological factors in insulin-dependent diabetes mellitus (type 1)].
    Pietruska Z
    Pol Arch Med Wewn; 1986 Dec; 76(5-6):285-90. PubMed ID: 3299306
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes.
    Eisenbarth GS; Moriyama H; Robles DT; Liu E; Yu L; Babu S; Redondo MJ; Gottlieb P; Wegmann D; Rewers M
    Autoimmun Rev; 2002 May; 1(3):139-45. PubMed ID: 12849007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of insulin-dependent diabetes mellitus].
    Balabolkin MI
    Probl Endokrinol (Mosk); 1985; 31(5):48-55. PubMed ID: 3906637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.
    Bottazzo GF; Genovese S; Bosi E; Dean BM; Christie MR; Bonifacio E
    Ann Med; 1991 Oct; 23(4):453-61. PubMed ID: 1930942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in relation to residual insulin secretion in children with IDDM.
    Ludvigsson J; Hellström S
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):81-9. PubMed ID: 9179462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Auto-immune physiopathology of diabetes type 1 (insulin-dependent)].
    Assan R; Laborie C; Boillot-Assan D
    Diabete Metab; 1988; 14(1):60-8. PubMed ID: 3292306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunopathology of insulin-dependent diabetes. New hypothesis].
    Serrano Rodríguez S; Pujol-Borrell R; Bottazzo GF
    Rev Clin Esp; 1986 Apr; 178(6):299-307. PubMed ID: 3523648
    [No Abstract]   [Full Text] [Related]  

  • 13. [Predicting the development of diabetes mellitus type 1].
    Jaskóła K; Bernaś M; Luźniak P; Szczeklik Z; Tatoń J
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):40-2. PubMed ID: 1409041
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies as predictors of type 1 diabetes.
    Wilkin TJ
    Compr Ther; 1991 Jul; 17(7):3-10. PubMed ID: 1742966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunology of diabetes. Immunologic markers].
    Castaño González L
    An Esp Pediatr; 1991 May; 34 Suppl 44():22-5. PubMed ID: 1741566
    [No Abstract]   [Full Text] [Related]  

  • 16. Epitope analysis of insulin autoantibodies using recombinant Fab.
    Padoa CJ; Crowther NJ; Thomas JW; Hall TR; Bekris LM; Torn C; Landin-Olsson M; Ortqvist E; Palmer JP; Lernmark A; Hampe CS
    Clin Exp Immunol; 2005 Jun; 140(3):564-71. PubMed ID: 15932520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes.
    Williams AJ; Bingley PJ; Chance RE; Gale EA
    J Autoimmun; 1999 Nov; 13(3):357-63. PubMed ID: 10550223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islet cells in tissue culture: function and immunoreactivity with serum autoantibodies from diabetes type-1 patients and monoclonal antibodies ICA-1.
    Zlobina EN; Rossels AN; Yesenin VI; Demin YM; Bachurin PS; Filatov AV; Brikova SV
    Exp Clin Endocrinol; 1989 May; 93(2-3):161-5. PubMed ID: 2673809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.